FDA
-
-
-
-
-
-
-
Keenova Reports First Quarter 2026 Financial Results
-
-
-
-
-
-
-
Keenova Marks 100K Peyronie's Disease Patients--a Major Milestone for an Often-Stigmatized Men's Health Condition
-
-
-
-
-
-
-
Mallinckrodt (MNK) Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 American Association for the Study of Liver Diseases
-
-
-
-
-
-
-
Mallinckrodt Announces Availability of Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector in the U.S.
-
-
-
-
-
-
-
Mallinckrodt Presents New Data on TERLIVAZ® (terlipressin) for Injection at the Society of Critical Care Medicine (SCCM) 2024 Critical Care Congress
-
-
-
-
-
-
-
Mallinckrodt (MNK) Presents Clinical Data for TERLIVAZ
-
-
-
-
-
-
-
Mallinckrodt (MNK) to Present New Retrospective Data on Effect of Acthar Gel
-
334,274 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


